Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J01 ANTIBACTERIALS FOR SYSTEMIC USE
J01M QUINOLONE ANTIBACTERIALS
J01MA Fluoroquinolones
J01MA14 Moxifloxacin
D00874 Moxifloxacin hydrochloride (JAN/USP) <JP/US>
S SENSORY ORGANS
S01 OPHTHALMOLOGICALS
S01A ANTIINFECTIVES
S01AE Fluoroquinolones
S01AE07 Moxifloxacin
D00874 Moxifloxacin hydrochloride (JAN/USP) <JP/US>
USP drug classification [BR:br08302]
Antibacterials
Quinolones
Moxifloxacin
D00874 Moxifloxacin hydrochloride (JAN/USP)
Ophthalmic Agents
Ophthalmic Anti-Infectives
Antibacterials, Ophthalmic
Moxifloxacin
D00874 Moxifloxacin hydrochloride (JAN/USP)
Therapeutic category of drugs in Japan [BR:br08301]
1 Agents affecting nervous system and sensory organs
13 Agents affecting sensory organs
131 Ophthalmic agents
1319 Others
D00874 Moxifloxacin hydrochloride (JAN/USP)
6 Agents against pathologic organisms and parasites
62 Chemotherapeutics
624 Synthetic antibacterials
6241 Pyridonecarboxylic acids
D00874 Moxifloxacin hydrochloride (JAN/USP)
Drug groups [BR:br08330]
Antibacterial
DG01550 Quinolone
DG01549 Fluoroquinolone
DG00626 Moxifloxacin
D00874 Moxifloxacin hydrochloride
Drug classes [BR:br08332]
Antibacterial
DG01549 Fluoroquinolone
D00874 Moxifloxacin hydrochloride
Antimicrobials [BR:br08307]
Antibacterials
Nucleic acid synthesis inhibitor
Fluoroquinolone
D00874 Moxifloxacin hydrochloride (JAN/USP) <JP/US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D00874
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D00874
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D00874
Drug groups [BR:br08330]
Antibacterial
DG01550 Quinolone
DG01549 Fluoroquinolone
DG00626 Moxifloxacin
Antimicrobials abbreviations [BR:br08327]
Antibacterials
Nucleic acid synthesis inhibitor
Fluoroquinolone
DG00626 Moxifloxacin